![](/img/cover-not-exists.png)
The FDA Outlook of Events Reporting after Ticagrelor or Clopidogrel in the PLATO Trial: Impact of Sponsor Censoring Dates, Drug Discontinuation, and Withdrawal of Consent
Serebruany, Victor L.Volume:
120
Year:
2011
Language:
english
Journal:
Cardiology
DOI:
10.1159/000335476
File:
PDF, 106 KB
english, 2011